About: David W Dodick

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: David W Dodick Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
description	wetenschapper (nl) дослідник (uk)
rdfs:label	David W Dodick (en) David W Dodick (nl) David Dodick (cs)
skos:prefLabel	David W Dodick (en) David W Dodick (nl) David Dodick (cs)
name	David W Dodick (en) David W Dodick (nl) David Dodick (cs)
given name	wds:Q78768282-C114979B-493B-4677-BAD2-68AA83B42E65
given name	David
instance of	wds:Q78768282-EE394C3F-4C5E-41A8-A152-A57986DF48CA
NL CR AUT ID	wds:Q78768282-778672C1-C08D-44D6-B468-CEE1F0BE1C43
instance of	Homo sapiens
NL CR AUT ID	xx0090171
occupation	wds:Q78768282-A68A1A62-AC1A-4CC2-A135-8EDA654E9950
sex or gender	wds:Q78768282-379D889B-E45D-4CFE-96C8-08D9417A54AF
ISNI	wds:Q78768282-5438B1BF-6DEB-48F1-B1CC-47FD497062C6
VIAF ID	wds:Q78768282-E3CB228F-9C3A-40DA-840A-32B6A430D371
GND ID	wds:Q78768282-DA89A92A-4B25-44AE-87EB-C9CBF0B3F6A8
IdRef ID	wds:Q78768282-337CEDAF-7C93-4E1E-807A-88296F549934
date of birth	wds:Q78768282-2803EEE9-4C5B-43F7-8DB3-C406C5B510D0
National Library of Israel J9U ID	wds:Q78768282-75937706-5715-4368-89F4-2C5734FBAAB0
National Library of Spain ID	wds:Q78768282-D6EB29FF-83B0-43B0-BF39-8C440316D195
VIAF ID	http://viaf.org/viaf/42175661
IdRef ID	http://www.idref.fr/127868690/id
National Library of Spain ID	http://datos.bne.es/resource/XX1386773
occupation	researcher
sex or gender	male
ISNI	0000000059370218
VIAF ID	42175661
IdRef ID	127868690
date of birth	1900-01-01 00:00:00Z (xsd:dateTime)
National Library of Israel J9U ID	987007363703405171
National Library of Spain ID	XX1386773
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q78768282
is author of	Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside Botulinum neurotoxin for the treatment of migraine and other primary headache disorders Stroke telemedicine Crescendo transient Aura attacks: a transient ischemic attack mimic caused by focal subarachnoid hemorrhage. Migraine prophylaxis with botulinum toxin A is associated with perception of headache Activation of TRPA1 on dural afferents: a potential mechanism of headache pain Indomethacin-responsive headache syndromes Removing barriers to appropriate migraine treatment: formulary limitations and triptan package size The impact of topiramate on health-related quality of life indicators in chronic migraine DHE in the pharmacotherapy of migraine: potential for a larger role Acute treatment and prevention of menstrually related migraine headache: evidence-based review Narrative review: reversible cerebral vasoconstriction syndromes Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study Diagnosis and Treatment of Cluster Headache Patent foramen ovale and migraine--bringing closure to the subject Patient-focused migraine management: establishing needs. Sustained-release niacin for prevention of migraine headache Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: results from a randomized, multicenter, double-blinded, controlled study Long-term outcome in occipital nerve stimulation patients with medically intractable primary headache disorders Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: long-term results from a randomized, multicenter, double-blinded, controlled study Smartphone teleradiology application is successfully incorporated into a telestroke network environment CT interpretation in a telestroke network: agreement among a spoke radiologist, hub vascular neurologist, and hub neuroradiologist OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program Triptan-induced latent sensitization: a possible basis for medication overuse headache Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Diagnostic criteria for headache due to spontaneous intracranial hypotension: a perspective Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial Transcranial magnetic stimulation for migraine: a safety review Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study. Cluster headache: diagnosis and treatment Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study Sensitivity of MRI of the spine compared with CT myelography in orthostatic headache with CSF leak. Introduction: cardiovascular safety and triptans in the acute treatment of migraine Pharmacological approaches to managing migraine and associated comorbidities--clinical considerations for monotherapy versus polytherapy Pathophysiology of medication overuse headache: insights and hypotheses from preclinical studies Debate: analgesic overuse is a cause, not consequence, of chronic daily headache. Analgesic overuse is not a cause of chronic daily headache Cardiovascular tolerability and safety of triptans: a review of clinical data Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studies Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study. Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database Stroke team remote evaluation using a digital observation camera in Arizona: the initial mayo clinic experience trial Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate Clinical, anatomical, and physiologic relationship between sleep and headache Advanced neuroimaging of migraine Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine Increased susceptibility to cortical spreading depression in an animal model of medication-overuse headache Canadian Headache Society systematic review and recommendations on the treatment of migraine pain in emergency settings Treatment of medication-overuse headache: A systematic review Operational diagnostic criteria for chronic migraine: expert opinion Capturing the aversive state of cephalic pain preclinically Targeting TRP channels for novel migraine therapeutics Refining the clinical spectrum of chronic paroxysmal hemicrania: a review of 74 patients Patient perceptions and treatment preferences in migraine management Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine Enhanced pain-induced activity of pain-processing regions in a case-control study of episodic migraine Caffeine for the prevention and treatment of postdural puncture headache: debunking the myth

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software